Literature DB >> 31463780

Vaspin protects mouse mesenchymal stem cells from oxidative stress-induced apoptosis through the MAPK/p38 pathway.

Xiao Zhu1, Lingyan Zhang2, Youming Chen3, Bo Chen4, Haifeng Huang5, Jicheng Lv1, Shidi Hu1, Jie Shen6.   

Abstract

The aim of the work was to study the influence of vaspin on oxidative stress-induced apoptosis of mouse mesenchymal stem cells (MSCs). MSCs originated from bone marrow of C57BL/6 mouse were treated with vaspin and/or H2O2 in a dose-dependent manner. Cellular viability detected by CCK-8 and cell apoptosis studied by flow cytometry and TUNEL assay were observed in these cells. The protein expressions of PI3K, p-PI3K, Akt, p-Akt, T-ERK1/2, p-ERK1/2, p38, p-p38, JNK, and p-JNK were tested by Western blot. Vaspin had no significant effect on cellular viability, but significantly reduced H2O2-induced apoptosis. Western blot assay showed that pretreatment with vaspin promoted the activation of p-p38. Inhibition of p38 by SB203580 suppressed the protective effect of vaspin on oxidative stress-induced apoptosis. Vaspin inhibits oxidative stress-induced apoptosis of MSCs via the activation of MAPK/p38 signaling pathway. These findings indicate that vaspin is prone to osteoporosis protection.

Entities:  

Keywords:  Apoptosis; Mesenchymal stem cells; Vaspin

Mesh:

Substances:

Year:  2019        PMID: 31463780     DOI: 10.1007/s11010-019-03614-8

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  34 in total

1.  Gene expression profiles of early adipogenesis in human mesenchymal stem cells.

Authors:  Shih-Chieh Hung; Ching-Fang Chang; Hsiao-Li Ma; Tain-Hsiung Chen; Larry Low-Tone Ho
Journal:  Gene       Date:  2004-09-29       Impact factor: 3.688

Review 2.  Osteoporosis treatment: recent developments and ongoing challenges.

Authors:  Sundeep Khosla; Lorenz C Hofbauer
Journal:  Lancet Diabetes Endocrinol       Date:  2017-07-07       Impact factor: 32.069

3.  Epoxyeicosanoids suppress osteoclastogenesis and prevent ovariectomy-induced bone loss.

Authors:  Hanfeng Guan; Libo Zhao; Huijuan Cao; Anmin Chen; Jun Xiao
Journal:  FASEB J       Date:  2014-12-02       Impact factor: 5.191

4.  Ginsenoside-Rb2 displays anti-osteoporosis effects through reducing oxidative damage and bone-resorbing cytokines during osteogenesis.

Authors:  Qiang Huang; Bo Gao; Qiang Jie; Bo-Yuan Wei; Jing Fan; Hong-Yang Zhang; Jin-Kang Zhang; Xiao-Jie Li; Jun Shi; Zhuo-Jing Luo; Liu Yang; Jian Liu
Journal:  Bone       Date:  2014-06-13       Impact factor: 4.398

5.  Systemically administered rhBMP-2 promotes MSC activity and reverses bone and cartilage loss in osteopenic mice.

Authors:  Gadi Turgeman; Yoram Zilberman; Shuanhu Zhou; Pam Kelly; Ioannis K Moutsatsos; Yogendra P Kharode; Luis E Borella; Frederick J Bex; Barry S Komm; Peter V N Bodine; Dan Gazit
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

6.  Human mesenchymal stem cells as an in vitro model for human adipogenesis.

Authors:  Lenka Janderová; Michele McNeil; Angela N Murrell; Randall L Mynatt; Steven R Smith
Journal:  Obes Res       Date:  2003-01

7.  Protection by salidroside against bone loss via inhibition of oxidative stress and bone-resorbing mediators.

Authors:  Jin-Kang Zhang; Liu Yang; Guo-Lin Meng; Zhi Yuan; Jing Fan; Dan Li; Jian-Zong Chen; Tian-Yao Shi; Hui-Min Hu; Bo-Yuan Wei; Zhuo-Jing Luo; Jian Liu
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

Review 8.  Stem cell technology for bone regeneration: current status and potential applications.

Authors:  Greg Asatrian; Dalton Pham; Winters R Hardy; Aaron W James; Bruno Peault
Journal:  Stem Cells Cloning       Date:  2015-02-10

Review 9.  Osteoporosis: the current status of mesenchymal stem cell-based therapy.

Authors:  Jitrada Phetfong; Tanwarat Sanvoranart; Kuneerat Nartprayut; Natakarn Nimsanor; Kanokwan Seenprachawong; Virapong Prachayasittikul; Aungkura Supokawej
Journal:  Cell Mol Biol Lett       Date:  2016-08-12       Impact factor: 5.787

10.  A novel pyrazole derivative protects from ovariectomy-induced osteoporosis through the inhibition of NADPH oxidase.

Authors:  Jung Hee Joo; Jeong-Eun Huh; Jee Hyun Lee; Doo Ri Park; Yoonji Lee; Seul Gee Lee; Sun Choi; Hwa Jeong Lee; Seong-Won Song; Yongmi Jeong; Ja-Il Goo; Yongseok Choi; Hye Kyung Baek; Sun Shin Yi; Soo Jin Park; Ji Eun Lee; Sae Kwang Ku; Won Jae Lee; Kee-In Lee; Soo Young Lee; Yun Soo Bae
Journal:  Sci Rep       Date:  2016-03-15       Impact factor: 4.379

View more
  5 in total

Review 1.  Mesenchymal Stem Cells Transplantation in Intracerebral Hemorrhage: Application and Challenges.

Authors:  Yu-Hua Gong; Shi-Lei Hao; Bo-Chu Wang
Journal:  Front Cell Neurosci       Date:  2021-03-24       Impact factor: 5.505

2.  Effect of Ibandronate Therapy on Serum Chemerin, Vaspin, Omentin-1 and Osteoprotegerin (OPG) in Postmenopausal Osteoporotic Females.

Authors:  Saba Tariq; Sundus Tariq; Shahad Abduljalil Abualhamael; Muhammad Shahzad
Journal:  Front Pharmacol       Date:  2022-02-09       Impact factor: 5.810

3.  Hexarelin Modulation of MAPK and PI3K/Akt Pathways in Neuro-2A Cells Inhibits Hydrogen Peroxide-Induced Apoptotic Toxicity.

Authors:  Ramona Meanti; Laura Rizzi; Elena Bresciani; Laura Molteni; Vittorio Locatelli; Silvia Coco; Robert John Omeljaniuk; Antonio Torsello
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-08

4.  Novel Insights on the Corpus Luteum Function: Role of Vaspin on Porcine Luteal Cell Angiogenesis, Proliferation and Apoptosis by Activation of GRP78 Receptor and MAP3/1 Kinase Pathways.

Authors:  Patrycja Kurowska; Ewa Mlyczyńska; Joelle Dupont; Agnieszka Rak
Journal:  Int J Mol Sci       Date:  2020-09-17       Impact factor: 5.923

Review 5.  The Role of Anti-Inflammatory Adipokines in Cardiometabolic Disorders: Moving beyond Adiponectin.

Authors:  Han Na Jung; Chang Hee Jung
Journal:  Int J Mol Sci       Date:  2021-12-16       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.